Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives; Future Implications on Sentinel Lymph Node Biopsy in LMIC: A Single-center Cross-sectional Study

NCT05771454 is registered in ClinicalTrials.gov with Aga Khan University Hospital, Pakistan as lead sponsor.

NCT NCT05771454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05771454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives; Future Implications on Sentinel Lymph Node Biopsy in LMIC: A Single-center Cross-sectional Study
Lead sponsor
Aga Khan University Hospital, Pakistan
Phase
Observational
Overall status
Completed
Start date
January 1, 2023
Completion date
March 30, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca mutation, breast cancer, genetic predisposition, occult cancer